| Batch Notification Number |
BN-OL-2022-10-03-5108
|
| FDA Registered Product/Generic Name |
Neomycin Sulfate + Dexamethasone Sodium Phosphate + Polymyxin B Sulfate
|
| Brand Name |
Otixin
|
| Dosage Strength |
5 mg/ 1 mg/ 10,000 Units per mL
|
| Dosage Form |
Solution Otic
|
| Registration Number |
DRP-11255
|
| Batch Number |
N/A
|
| Lot Number |
2B25C
|
| Product Expiration Date |
09/2025
|
| Issuance Date |
5 October 2022
|